$1.29 Billion is the total value of Slate Path Capital LP's 10 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 57.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | New | SPDR S&P 500 ETF TRcall | $328,832,000 | – | 1,600,000 | +100.0% | 25.53% | – |
GDX | Buy | MARKET VECTORS ETF TRgold miner etf | $207,488,000 | +142.4% | 10,390,000 | +66.5% | 16.11% | +73.9% |
PYPL | Buy | PAYPAL HLDGS INC | $206,317,000 | +20.6% | 5,345,000 | +13.1% | 16.02% | -13.4% |
CHTR | Buy | CHARTER COMMUNICATIONS INC Dcl a new | $152,835,000 | +21.0% | 755,000 | +9.4% | 11.87% | -13.2% |
TRIP | Buy | TRIPADVISOR INC | $104,738,000 | +22.6% | 1,575,000 | +57.1% | 8.13% | -12.0% |
PODD | INSULET CORP | $90,195,000 | -12.3% | 2,720,000 | 0.0% | 7.00% | -37.1% | |
TSO | TESORO CORP | $85,580,000 | -18.4% | 995,000 | 0.0% | 6.64% | -41.4% | |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $71,244,000 | +4.4% | 1,135,000 | +56.6% | 5.53% | -25.1% |
TWC | Sell | TIME WARNER CABLE INC | $22,508,000 | -34.4% | 110,000 | -40.5% | 1.75% | -52.9% |
OPHT | New | OPHTHOTECH CORP | $18,176,000 | – | 430,000 | +100.0% | 1.41% | – |
KMI | Exit | KINDER MORGAN INC DEL | $0 | – | -1,030,000 | -100.0% | -1.66% | – |
CPGX | Exit | COLUMBIA PIPELINE GROUP INC | $0 | – | -805,000 | -100.0% | -1.74% | – |
WMB | Exit | WILLIAMS COS INC DEL | $0 | – | -660,000 | -100.0% | -1.84% | – |
OKE | Exit | ONEOK INC NEW | $0 | – | -805,000 | -100.0% | -2.15% | – |
MDCO | Exit | MEDICINES CO | $0 | – | -570,000 | -100.0% | -2.30% | – |
Z | Exit | ZILLOW GROUP INCcl c cap stk | $0 | – | -2,385,000 | -100.0% | -6.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
Stitch Fix, Inc. | February 14, 2023 | ? | ? |
Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-01-22 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G | 2023-02-14 |
13F-HR | 2023-02-14 |
SC 13G | 2023-01-13 |
SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.